Optipharm.CO.,LTD (KOSDAQ: 153710)
South Korea
· Delayed Price · Currency is KRW
4,795.00
-40.00 (-0.83%)
Dec 20, 2024, 12:51 PM KST
Optipharm.CO.,LTD Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
Net Income | -2,269 | -2,437 | -2,045 | -3,080 | -2,352 | -655.33 | Upgrade
|
Depreciation & Amortization | 1,576 | 1,433 | 1,120 | 1,076 | 984.42 | 856.68 | Upgrade
|
Loss (Gain) From Sale of Assets | 0.33 | -1.06 | -3.05 | 1.76 | -13.6 | 5.47 | Upgrade
|
Loss (Gain) From Sale of Investments | -125.35 | -184.65 | -346.47 | -90.2 | -22.23 | -45.47 | Upgrade
|
Loss (Gain) on Equity Investments | 1.17 | 1.49 | 0.35 | 0.29 | 10.44 | - | Upgrade
|
Stock-Based Compensation | 411.13 | - | -33.61 | -5.9 | 103.18 | 254.35 | Upgrade
|
Provision & Write-off of Bad Debts | 3.5 | -0.2 | -0.33 | 1.29 | 0.01 | 0.05 | Upgrade
|
Other Operating Activities | 344.38 | 362.29 | 298.11 | -1,063 | -493.44 | 62.15 | Upgrade
|
Change in Accounts Receivable | 462.36 | 476.25 | -899.4 | -95.74 | 84.19 | 85.74 | Upgrade
|
Change in Inventory | -393.52 | -261.97 | -42.84 | -339.3 | -43.09 | 53.73 | Upgrade
|
Change in Accounts Payable | 278.55 | 152.63 | -631.57 | 226.52 | 254.8 | -344.46 | Upgrade
|
Change in Other Net Operating Assets | -639.33 | -1,264 | 187.12 | 1,399 | -128.91 | 174.57 | Upgrade
|
Operating Cash Flow | -349.43 | -1,723 | -2,396 | -1,969 | -1,617 | 447.47 | Upgrade
|
Operating Cash Flow Growth | - | - | - | - | - | -62.81% | Upgrade
|
Capital Expenditures | -1,198 | -1,672 | -4,572 | -725.18 | -890.76 | -626.46 | Upgrade
|
Sale of Property, Plant & Equipment | 0.3 | 1.7 | 5.93 | 11.81 | 29.06 | 0.27 | Upgrade
|
Sale (Purchase) of Intangibles | -81.85 | -65.25 | -32.27 | -32.26 | -63.8 | -129.02 | Upgrade
|
Investment in Securities | 5,901 | -1,854 | 2,621 | -6,789 | -3,138 | -5,201 | Upgrade
|
Other Investing Activities | -36.05 | - | - | 147.56 | 107.35 | -0 | Upgrade
|
Investing Cash Flow | 4,585 | -3,589 | -1,978 | -7,387 | -3,956 | -5,956 | Upgrade
|
Short-Term Debt Issued | - | 7,700 | 5,200 | 5,100 | 1,300 | - | Upgrade
|
Long-Term Debt Issued | - | - | - | - | 10 | - | Upgrade
|
Total Debt Issued | 9,200 | 7,700 | 5,200 | 5,100 | 1,310 | - | Upgrade
|
Short-Term Debt Repaid | - | -5,560 | -3,560 | -3,560 | -360 | -1,060 | Upgrade
|
Long-Term Debt Repaid | - | -147.29 | -130.41 | -156.45 | -144.54 | -109.48 | Upgrade
|
Total Debt Repaid | -8,233 | -5,707 | -3,690 | -3,716 | -504.54 | -1,169 | Upgrade
|
Net Debt Issued (Repaid) | 967.25 | 1,993 | 1,510 | 1,384 | 805.46 | -1,169 | Upgrade
|
Issuance of Common Stock | - | - | 250.5 | 435 | 300.1 | 585.5 | Upgrade
|
Other Financing Activities | -0 | -0 | -0 | -0 | -0 | -0 | Upgrade
|
Financing Cash Flow | 967.25 | 1,993 | 1,760 | 1,819 | 1,106 | -583.98 | Upgrade
|
Miscellaneous Cash Flow Adjustments | 0 | -0 | - | - | - | - | Upgrade
|
Net Cash Flow | 5,203 | -3,319 | -2,613 | -7,538 | -4,467 | -6,093 | Upgrade
|
Free Cash Flow | -1,548 | -3,395 | -6,968 | -2,695 | -2,507 | -178.99 | Upgrade
|
Free Cash Flow Margin | -8.11% | -19.54% | -43.53% | -18.90% | -19.22% | -1.31% | Upgrade
|
Free Cash Flow Per Share | -105.75 | -231.40 | -477.09 | -185.50 | -173.74 | -12.56 | Upgrade
|
Cash Interest Paid | 743.01 | 463.38 | 319.85 | 158.37 | 95.89 | 156.07 | Upgrade
|
Cash Income Tax Paid | 8.82 | 36.58 | 36.09 | -31.66 | -17.53 | 65.64 | Upgrade
|
Levered Free Cash Flow | -593.18 | -2,006 | -6,486 | -2,171 | -2,843 | -630.53 | Upgrade
|
Unlevered Free Cash Flow | -258.99 | -1,708 | -6,265 | -2,062 | -2,775 | -531.42 | Upgrade
|
Change in Net Working Capital | -518.85 | -240.83 | 1,380 | -440.97 | 749.55 | 142.59 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.